J K Baird

Summary

Affiliation: Naval Medical Center
Country: USA

Publications

  1. ncbi request reprint Primaquine for prevention of malaria in travelers
    J Kevin Baird
    US Naval Medical Research Center Detachment, Lima, Peru
    Clin Infect Dis 37:1659-67. 2003
  2. ncbi request reprint Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua
    J K Baird
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:557-64. 2003
  3. ncbi request reprint Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua
    M J Barcus
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:565-74. 2003
  4. ncbi request reprint Malaria in a cohort of Javanese migrants to Indonesian Papua
    - Krisin
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:543-56. 2003
  5. ncbi request reprint Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia
    J K Baird
    Parasitic Diseases Program, US Naval Medical Research Unit 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Clin Infect Dis 33:1990-7. 2001
  6. ncbi request reprint Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia
    J D Maguire
    U S Naval Medical Research Unit 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 96:655-68. 2002
  7. ncbi request reprint The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia
    J D Maguire
    United States Naval Medical Research Unit No 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 95:559-72. 2001
  8. doi request reprint The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies
    J D Maguire
    Naval Medical Center Portsmouth, VA 23708, USA
    Ann Trop Med Parasitol 104:283-301. 2010
  9. ncbi request reprint Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum
    J K Baird
    Malaria Program, Naval Medical Research Institute, Rockville, MD 20852, USA
    Ann Trop Med Parasitol 92:367-90. 1998
  10. ncbi request reprint The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia
    D J Fryauff
    Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910 7500, USA
    Ann Trop Med Parasitol 96:447-62. 2002

Collaborators

Detail Information

Publications51

  1. ncbi request reprint Primaquine for prevention of malaria in travelers
    J Kevin Baird
    US Naval Medical Research Center Detachment, Lima, Peru
    Clin Infect Dis 37:1659-67. 2003
    ..Primaquine's major advantage over most drugs for chemoprophylaxis is that it does not have to be taken before entering or beyond 3 days after leaving a malarious area...
  2. ncbi request reprint Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua
    J K Baird
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:557-64. 2003
    ..6; CI=1.7-530; P=0.005), indicating the development of clinical immunity. A similar but less marked pattern appeared among the children investigated (OR=6.5; CI=0.8-285; P=0.06)...
  3. ncbi request reprint Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua
    M J Barcus
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:565-74. 2003
    ..falciparum and P. vivax...
  4. ncbi request reprint Malaria in a cohort of Javanese migrants to Indonesian Papua
    - Krisin
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:543-56. 2003
    ..Only one of the nine subjects who developed severe malaria (requiring intravenous quinine therapy) was a child, giving an odds ratio for a case of severe malaria being in an adult of 6.1 (P=0.08)...
  5. ncbi request reprint Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia
    J K Baird
    Parasitic Diseases Program, US Naval Medical Research Unit 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Clin Infect Dis 33:1990-7. 2001
    ..Good safety, tolerance, and efficacy, along with key advantages in dosing requirements, make primaquine an excellent drug for preventing malaria in nonpregnant, G6PD-normal travelers...
  6. ncbi request reprint Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia
    J D Maguire
    U S Naval Medical Research Unit 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 96:655-68. 2002
    ..vivax. Chloroquine was thus an ineffective therapy for P. falciparum malaria, and the presence of CQ-resistant P. vivax and SP-resistant P. falciparum will further compromise efforts to control resurgent malaria on Java...
  7. ncbi request reprint The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia
    J D Maguire
    United States Naval Medical Research Unit No 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 95:559-72. 2001
    ..Validation requires exploration of the phenotype classifications based on the results of in-vivo tests, using genetic analyses that distinguish re-infection from recrudescence and detect microscopically subpatent parasitaemias...
  8. doi request reprint The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies
    J D Maguire
    Naval Medical Center Portsmouth, VA 23708, USA
    Ann Trop Med Parasitol 104:283-301. 2010
    ....
  9. ncbi request reprint Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum
    J K Baird
    Malaria Program, Naval Medical Research Institute, Rockville, MD 20852, USA
    Ann Trop Med Parasitol 92:367-90. 1998
    ..falciparum, and whether that response is relatively harmful or beneficial may depend upon the conditions of exposure (i.e. acute or chronic)...
  10. ncbi request reprint The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia
    D J Fryauff
    Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910 7500, USA
    Ann Trop Med Parasitol 96:447-62. 2002
    ..sundaicus...
  11. ncbi request reprint Chloroquine for the treatment of uncomplicated malaria in Guyana
    J K Baird
    U S Naval Medical Research Unit 2, American Embassy Jakarta, Fleet Post Office Asia Pacific 96520 8132, U S A
    Ann Trop Med Parasitol 96:339-48. 2002
    ..e. <100 ng/ml). Taken together, the results indicate a high risk of therapeutic failure of CQ against P. falciparum but also indicate that resistance to CQ in P. vivax occurs infrequently in Guyana...
  12. pmc Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques
    W O Rogers
    Malaria Program, Naval Medical Research Center, Silver Spring, Maryland 20910, Bethesda, Maryland 20889, USA
    Infect Immun 69:5565-72. 2001
    ..This model will be important in preclinical vaccine development...
  13. pmc Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency
    Jason D Maguire
    U S Naval Medical Research Unit No 2 NAMRU 2, Jakarta, Indonesia
    Malar J 5:92. 2006
    ..Sets of Giemsa-stained, blood smear slides with systematically verified composite diagnoses would contribute substantially to development of externally validated quality assurance systems for the microscopic diagnosis of malaria...
  14. ncbi request reprint Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I
    David R Hill
    National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine Mortimer Market Centre, London, England
    Am J Trop Med Hyg 75:402-15. 2006
    ..The adult dose for primary prophylaxis is 30 mg daily begun 1 day before travel and continued for 7 days after return. This review will examine the evidence for these recommendations...
  15. ncbi request reprint Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia
    Jason D Maguire
    US Naval Medical Research Unit No 2, Jakarta, Indonesia
    Clin Infect Dis 42:1067-72. 2006
    ..During the period of 1996-1999, we prospectively monitored 243 Javanese adults and children after arriving in Papua, Indonesia, and microscopically documented each new case of malaria by active surveillance...
  16. ncbi request reprint Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia
    J Teun Bousema
    Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
    Am J Trop Med Hyg 74:425-31. 2006
    ..74, 95% confidence interval [CI] = 1.51-9.29) and Pfs230 (OR = 3.72, 95% CI = 1.36-10.17) suggests that functional transmission reducing immunity is acquired after limited exposure to infection...
  17. ncbi request reprint Effectiveness of antimalarial drugs
    J Kevin Baird
    U S Naval Medical Research Unit No 2, Jakarta, Indonesia
    N Engl J Med 352:1565-77. 2005
  18. ncbi request reprint Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains
    Juliana Martha Sá
    Departamento de Parasitologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Av Lineu Prestes 1374, Sao Paulo SP, 05508 900, Brazil
    Exp Parasitol 109:256-9. 2005
    ..Similarity and dendrogram analyses revealed that sequences could be grouped according to their geographical origin. Within each geographical group however, no correlation was found between chloroquine resistance and specific mutations...
  19. ncbi request reprint Molecular epidemiology of Plasmodium falciparum resistance to antimalarial drugs in Indonesia
    Din Syafruddin
    Eijkman Institute for Molecular Biology, Jakarta, Indonesia
    Am J Trop Med Hyg 72:174-81. 2005
    ..The pfmdr1 1042-Asp polymorphism occurred less frequently. These findings indicate that polymorphisms in genes associated with drug resistance in P. falciparum are found across a broad region of Indonesia...
  20. doi request reprint Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections
    E Elsa Herdiana Murhandarwati
    Department of Microbiology, Monash University, Clayton, Victoria, Australia
    J Infect Dis 198:1212-8. 2008
    ..This delay in the acquisition of functional antibodies by residents of areas where malaria is endemic is consistent with the observation that multiple malaria infections are required before clinical immunity is acquired...
  21. pmc High-dose primaquine regimens against relapse of Plasmodium vivax malaria
    Srivicha Krudsood
    Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Am J Trop Med Hyg 78:736-40. 2008
    ..Treatment of P. vivax malaria with artesunate for 5 days followed by high-dose primaquine, 30 mg twice a day for 7 days, was highly effective, well-tolerated, and equivalent or superior to the standard regimen of primaquine therapy...
  22. pmc Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum
    Rajeev K Mehlotra
    Center for Global Health and Diseases, Case Western Reserve University, School of Medicine, Wolstein Research Building, room no 4204, 2103 Cornell Road, Cleveland, OH 44106 7286, USA
    Antimicrob Agents Chemother 52:2212-22. 2008
    ....
  23. ncbi request reprint Neglect of Plasmodium vivax malaria
    J Kevin Baird
    ALERTAsia Foundation, Jalan Diponegoro No 69, Menteng, Jakarta, Pusat, Indonesia
    Trends Parasitol 23:533-9. 2007
    ..Misdiagnosis of species now affects clinical decisions resulting in inadequate therapy for P. falciparum and P. vivax. All of these factors demonstrate the lack of research on P. vivax...
  24. pmc World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs
    Ric N Price
    International Health Program, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
    Malar J 6:119. 2007
    ..This resource will help guide rational drug policies that optimize antimalarial drug use, in the hope that the emergence and spread of resistance to new drugs can be, if not prevented, at least delayed...
  25. pmc Acquired immunity in a holoendemic setting of Plasmodium falciparum and p. Vivax malaria
    J Kevin Baird
    Am J Trop Med Hyg 76:995-6. 2007
  26. ncbi request reprint Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana
    David J Fryauff
    US Naval Medical Research Unit No 3, Cairo, Egypt
    Am J Trop Med Hyg 76:224-31. 2007
    ..An observed recurrent parasitemia of 34,400 trophozoites/microL against a MQ blood concentration of 550 ng/mL was taken as indication of tolerance to suppressive levels of the drug at this location...
  27. ncbi request reprint Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua
    Mazie J Barcus
    US Naval Medical Research Unit 2, Jakarta, Indonesia
    Am J Trop Med Hyg 77:984-91. 2007
    ..748). This study compares admissions per population (based on census data), parasitemia, morbidity, and mortality among children versus adults, pregnant versus non-pregnant women, and urban/suburban versus rural residents...
  28. ncbi request reprint A rare glimpse at the efficacy of primaquine
    J Kevin Baird
    Am J Trop Med Hyg 76:201-2. 2007
  29. ncbi request reprint Survey of community knowledge, attitudes, and practices during a malaria epidemic in central Java, Indonesia
    Parsa Sanjana
    Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    Am J Trop Med Hyg 75:783-9. 2006
    ..This assessment of knowledge, attitudes, and practices showed a broad awareness of malaria and its consequences among residents of malarial areas in the Menoreh Hills of Central Java...
  30. pmc Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
    Edith R Lederman
    US Naval Medical Research Unit No 2, Jakarta, Indonesia
    Malar J 5:108. 2006
    ..Combining CQ with other drugs, like SP, may provide an affordable, available and effective option where artemisinin-combined therapies (ACT) are not licensed or are unavailable...
  31. pmc Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system
    Michele D Hastings
    Department of Genome Sciences, Box 357730, University of Washington, Seattle, WA 98195 7730, USA
    Antimicrob Agents Chemother 49:733-40. 2005
    ..This study expands significantly the total number of novel dhfr alleles now identified from P. vivax and provides a foundation for understanding how antifolate resistance arises and spreads in natural P. vivax populations...
  32. ncbi request reprint Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia
    Jason D Maguire
    United States Naval Medical Research Unit 2, Jakarta, Indonesia
    Lancet 360:58-60. 2002
    ..These findings suggest that clinical resistance to chloroquine by P malariae occurs in the Indonesian archipelago of southeast Asia...
  33. ncbi request reprint Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia
    Judith Ling
    Naval Medical Research Unit 2, Jakarta, Indonesia
    Clin Infect Dis 35:825-33. 2002
    ..Atovaquone/proguanil was well tolerated, safe, and effective for the prevention of drug-resistant P. vivax and P. falciparum malaria in individuals without prior malaria exposure who migrated to Papua, Indonesia...
  34. ncbi request reprint Seasonal malaria attack rates in infants and young children in northern Ghana
    J Kevin Baird
    Naval Medical Research Center, Silver Spring, Maryland, USA
    Am J Trop Med Hyg 66:280-6. 2002
    ..These findings bear upon the design of malaria drug and vaccine trials in holoendemic areas...
  35. ncbi request reprint Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia
    J Kevin Baird
    US Naval Medical Research Unit No 2, American Embassy Jakarta, Indonesia
    Am J Trop Med Hyg 66:659-60. 2002
    ..2; 95% CI, 0.1-1.8; P = 0.2) or day 28 (82% versus 93%; OR, 0.31; 95% Cl, 0.04-2.1; P = 0.23). This report corroborates studies suggesting that therapeutic doses of primaquine exert no discernible effect on parasitemia by P. falciparum...
  36. ncbi request reprint Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity
    Mark D Lacy
    Parasitic Diseases Program, US Naval Medical Research Unit 2, Jakarta, Indonesia
    Clin Infect Dis 35:e92-5. 2002
    ..Atovaquone/proguanil provided safe, well-tolerated, and effective therapy for uncomplicated malaria in nonimmune Indonesians...
  37. ncbi request reprint A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum
    Braden R Hale
    US Navy Medical Research Unit No 3, Cairo, Egypt
    Clin Infect Dis 36:541-9. 2003
    ..Tafenoquine dosages of 50, 100, and 200 mg/week were safe, well tolerated, and effective against P. falciparum infection in this study population...
  38. ncbi request reprint Can primaquine therapy for vivax malaria be improved?
    J Kevin Baird
    US Naval Medical Research Unit 2, American Embassy Jakarta, Fleet Post Office, Asia Pacific 96520 8132, USA
    Trends Parasitol 19:115-20. 2003
    ..Resistance to standard therapy could be widespread. Studies are urgently needed to gauge this problem and to determine the safety, tolerability and efficacy of shorter courses and higher doses of PQ...
  39. ncbi request reprint New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates
    Hadya S Nagesha
    The Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia
    Am J Trop Med Hyg 68:398-402. 2003
    ....
  40. ncbi request reprint Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia
    Sarah N Hudson Keenihan
    United States Navy Medical Research Unit 2, Jakarta, Indonesia
    Am J Trop Med Hyg 69:36-41. 2003
    ..2, 95% CI = 0.5-2.8, P = 0.60). Host age, independent of cumulative exposure, apparently represents a key determinant of the quantitative and qualitative nature of the IgG response to P. falciparum GPI...
  41. pmc Chloroquine resistance in Plasmodium vivax
    J Kevin Baird
    U S Naval Medical Research Center Detachment, American Embassy Lima, APO AP 34031, USA
    Antimicrob Agents Chemother 48:4075-83. 2004
  42. ncbi request reprint Primaquine therapy for malaria
    J Kevin Baird
    US Naval Medical Research Center Detachment, Lima, Peru
    Clin Infect Dis 39:1336-45. 2004
    ..5 mg/kg primaquine daily for 14 days, on the basis of superior efficacy and good tolerability and safety in nonpregnant persons without glucose-6-phosphate dehydrogenase deficiency...
  43. ncbi request reprint Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine
    Michele D Hastings
    Department of Genome Sciences, School of Medicine, University of Washington, Seattle, WA 98195 7730, USA
    J Infect Dis 189:744-50. 2004
    ..Still less is known about associations between specific alleles and the failure of sulfadoxine/pyrimethamine (S/P) to clear the erythrocytic stages of P. vivax in vivo...
  44. ncbi request reprint Short report: in vivo sensitivity of Plasmodium falciparum to halofantrine in southern central Vietnam
    Hanh Nhan Doan
    U S Naval Medical Research Unit No 2, Jakarta, Indonesia
    Am J Trop Med Hyg 69:553-4. 2003
    ..8-99.2%) patients were sensitive. Two patients had recurrent P. falciparum parasitemia on days 14 and 21. Halofantrine effectively treated uncomplicated P. falciparum malaria in these Vietnamese patients...
  45. ncbi request reprint Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua
    Iwa W Sumawinata
    United States Naval Medical Research Unit No 2, American Embassy, Jakarta, Indonesia
    Am J Trop Med Hyg 68:416-20. 2003
    ..These findings document almost complete failure of chloroquine against P. falciparum or P. vivax near the northeastern coast of Indonesian Papua...
  46. pmc Identification of a polymorphic Plasmodium vivax microsatellite marker
    John C Gomez
    Department of Pathology, Case Western Reserve University, Cleveland, OH 44106 4983, USA
    Am J Trop Med Hyg 69:377-9. 2003
    ..falciparum). The marker was polymorphic in P. vivax-infected field isolates obtained from Papua New Guinea, Indonesia and Guyana. This microsatellite marker may be useful in genetic and epidemiologic studies of P. vivax malaria...
  47. ncbi request reprint Short report: hepatitis b infection and severe Plasmodium falciparum malaria in Vietnamese adults
    Mazie J Barcus
    US Naval Medical Research Unit 2, Jakarta, Indonesia
    Am J Trop Med Hyg 66:140-2. 2002
    ..28; 95% confidence interval, 1.04-1.58) relative to other manifestations of severe malaria. Chronic infection with hepatitis B virus may be a risk factor for severe malaria...
  48. pmc A biologic basis for integrated malaria control
    F Ellis McKenzie
    Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Trop Med Hyg 67:571-7. 2002
    ..Success is more likely if programs are cognizant of local circumstances of transmission, and, within that context, aim to reduce vector survivorship and human infectivity as well as augment human immunity...
  49. ncbi request reprint Epidemic malaria in the Menoreh Hills of Central Java
    Mazie J Barcus
    U S Naval Medical Research Unit 2, Jakarta, Indonesia
    Am J Trop Med Hyg 66:287-92. 2002
    ..Reintroduced endemic malaria threatens the island of Java...
  50. ncbi request reprint Epidemiological measures of risk of malaria
    J Kevin Baird
    Parasitic Diseases Program, US Naval Medical Research Unit 2, Jakarta, Indonesia
    Methods Mol Med 72:13-22. 2002
  51. ncbi request reprint A focus of human infection by Haplorchis taichui (Trematoda: Heterophyidae) in the southern Philippines
    Vicente Y Belizario
    College of Public Health, University of the Philippines, Ermita, Manila, Philippines
    J Parasitol 90:1165-9. 2004
    ..The most common clinical symptoms appeared as upper abdominal discomfort or pain and borborygmi. Praziquantel (75 mg/kg divided in 3 doses in 1 day) was a well-tolerated and effective treatment for infection by H. taichui...